INTERNATIONAL ETHICAL REGULATIONS ON PLACEBO-USE IN CLINICAL TRIALS: A COMPARATIVE ANALYSIS
The ethical aspects of placebo control in clinical trials have been extensively and controversially debated in the last decade. However, a thorough analytical comparison of the different existing international regulations, their terminologies and their ethical principles concerning placebo, is still...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
2008
|
| In: |
Bioethics
Year: 2008, Volume: 22, Issue: 1, Pages: 64-74 |
| Further subjects: | B
ethical acceptability
B international regulations B placebo control B research ethics |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1781880867 | ||
| 003 | DE-627 | ||
| 005 | 20211211042757.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211211s2008 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1467-8519.2007.00587.x |2 doi | |
| 035 | |a (DE-627)1781880867 | ||
| 035 | |a (DE-599)KXP1781880867 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Ehni, Hans-Jörg |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a INTERNATIONAL ETHICAL REGULATIONS ON PLACEBO-USE IN CLINICAL TRIALS: A COMPARATIVE ANALYSIS |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The ethical aspects of placebo control in clinical trials have been extensively and controversially debated in the last decade. However, a thorough analytical comparison of the different existing international regulations, their terminologies and their ethical principles concerning placebo, is still missing. The central issue in the ongoing controversy is the justification of placebo-use, if proven treatment exists. All present versions of the examined guidelines propose such justifications, but each guideline differs from the others in relevant details. Therefore the conditions justifying placebo-use according to each guideline are the focus of our attention. We will first propose a formalized general principle that defines the ethical acceptability of placebo-use. Then we will analyse three categories of conditions put forward by the different documents: the risk of harm or burden, compelling scientific reasons, and the availability of proven treatment. The analysis shows important normative discrepancies and contradictions between the examined guidelines. Especially striking is the fact that some guidelines allow the participants in clinical trials to be exposed to a risk of serious harm, while others do not. Finally, we try to show how the normative difference of each guideline could influence the decision of researchers or IRBs concerning the ethical acceptabililty of placebo-use. | ||
| 650 | 4 | |a research ethics | |
| 650 | 4 | |a ethical acceptability | |
| 650 | 4 | |a international regulations | |
| 650 | 4 | |a placebo control | |
| 700 | 1 | |a Wiesing, Urban |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 22(2008), 1, Seite 64-74 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2008 |g number:1 |g pages:64-74 |
| 856 | 4 | 0 | |u https://doi.org/10.1111/j.1467-8519.2007.00587.x |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1467-8519.2007.00587.x |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 22 |j 2008 |e 1 |h 64-74 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 401900384X | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1781880867 | ||
| LOK | |0 005 20211211042757 | ||
| LOK | |0 008 211211||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2021-12-10#AD1D65C461215F66080AC6C5DC36138F4D287761 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||